Insider Transactions in Q3 2022 at Predictive Oncology Inc. (POAI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,199
-14.03%
|
$0
$0.39 P/Share
|
|
Sep 23
2022
|
Robert L Myers CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
33,333
+31.45%
|
-
|
|
Jul 01
2022
|
Nancy Chung Welch Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+29.11%
|
-
|
|
Jul 01
2022
|
Clair Gregory Sr St. Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+31.46%
|
-
|
|
Jul 01
2022
|
Raymond F Vennare CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+33.81%
|
-
|
|
Jul 01
2022
|
Charles Lee Sr Nuzum Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,704
+11.9%
|
-
|
|
Jul 01
2022
|
Christina Lee Md Jenkins |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+30.57%
|
-
|
|
Jul 01
2022
|
Daniel E Handley Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,700
+28.04%
|
-
|